Interim results for the phase II study of panobinostat (LBH589) in patients (Pts) with relapsed/refractory Hodgkin's lymphoma (HL) after autologous hematopoietic stem cell transplant (AHSCT)
Sureda, A., Engert, A., Browett, P. J., Radford, J. A., Verhoef, G. E., Ramchandren, R., Myke, N., Shen, A., Le Corre, C., Younes, A.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A drug interaction study between ketoconazole and panobinostat (LBH589), an orally active histone deacetylase inhibitor, in patients with advanced cancer
DeJonge, M., Woo, M. M., Van der Biessen, D., Hamberg, P., Sharma, S., Chen, L. C., Myke, N., Zhao, L., Hirawat, S., Verweij, J.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article